Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendate

References

• Bunjes H, Westesen K, Koch MHJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 1996; 129: 159–73
   Web of Science ®Google Scholar
• Chen ZP, Zhu JB, Chen HX, Xiao YY. A simple HPLC method for the determination of bifendate: Application to a pharmacokinetic study of bifendate liposome. J Chromatogr B 2007; 857: 246–50
   PubMed Web of Science ®Google Scholar
• Dingler A, Blum RP, Niehus H, Müller RHS. Gohla, Solid lipid nanoparticles (SLN™/Lipopearls™) – A pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J Microencapsul 1999; 16: 751–67
   PubMed Web of Science ®Google Scholar
• Doktorovová S, Araújo J, Garciab ML, Rakovsky′ E, Souto EB. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf B: Biointerface 2010; 75: 538–42
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang DR, Chen MH, Duan CX, Dai WT, Jia LJ, Zhao WF. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. Int J Pharm 2008; 355: 321–27
   PubMed Web of Science ®Google Scholar
• Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B: Biointerface 2005; 45: 167–73
   PubMed Web of Science ®Google Scholar
• Hu L, Tang X, Cui F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 2004; 56: 1527–35
   PubMed Web of Science ®Google Scholar
• Jenning V, Thünemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000; 199: 167–77
   PubMed Web of Science ®Google Scholar
• Jia LJ, Zhang DR, Li ZY, Duan CX, Wang YC, Feng FF, Wang FH, Liu Y, Zhang Q. Tissue distribution and pharmacokinetic evaluation of nanostructured lipid carriers for intravenous delivery of silybin. Colloids Surf B: Biointerfaces 2010b; 80: 213–18
   PubMed Web of Science ®Google Scholar
• Jia LJ, Zhang DR, Li ZY, Feng FF, Wang YC, Dai WT, Duan CXi, Zhang Q. Preparation and characterization of silybin-loaded nanostructured lipid carriers. Drug Deliv 2010a; 17: 11–8
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release 2004; 95: 217–27
   PubMed Web of Science ®Google Scholar
• Joshi MD, Müller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 2009; 71: 161–72
   PubMed Web of Science ®Google Scholar
• Kwon JT, Hwang SK, Jin H, Kim DS, Minai Tehrani A, Yoon HJ, Choi M, Yoon TJ, Han DY, Kang YW, et al. Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health 2008; 50: 1–6
   PubMed Web of Science ®Google Scholar
• Li HL, Zhao XB, Ma YK, Zhai GX, Li LB, Lou HX. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 2009; 133: 238–44
   PubMed Web of Science ®Google Scholar
• Lim SJ, Kim CK. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-transretinoic acid. Int J Pharm 2002; 243: 135–46
   PubMed Web of Science ®Google Scholar
• Lim S, Lee M, Kim C. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Control Release 2004; 100: 53–61
   PubMed Web of Science ®Google Scholar
• Lin XH, Li XW, Zheng LQ, Yu Li, Zhang QQ, Liu WC. Preparation and characterization of monocaprate nanostructured lipid carriers. Colloids Surf A: Physicochem Eng Aspects 2007; 311: 106–111
   Web of Science ®Google Scholar
• Lu W, He LC, Wang CH, Li YH, Zhang SQ. The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice. Int J Biol Macromol 2008; 43: 320–24
   PubMed Web of Science ®Google Scholar
• Lv QZ, Yu AH, Xia YW, Li HL, Song ZM, Cui J, Cao FL, Zhai GX. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm 2009; 372: 191–98
   PubMed Web of Science ®Google Scholar
• Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release 2005; 107: 215–28
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001; 47: 165–96
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009; 366: 170–84
   PubMed Web of Science ®Google Scholar
• Shen J, Wang Y, Ping QN, Xiao YY, Huang X. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Control Release 2009; 137: 217–23
   PubMed Web of Science ®Google Scholar
• Shen B, Ye Y, Ding J. In vivo tissues distribution pharmacokinetics: Survey of 2 kinds of monostearin solid lipid nanoparticles. Zhongguo Yaofang 2006; 17: 253–55
   Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004; 278: 71–7
   PubMed Web of Science ®Google Scholar
• Sun JY, Zhou ZF, Liu F, Chen GS. Pharmacokinetics and tissue distribution of oxymatrine-SLN. Chin Pharm J 2007; 42: 1091–95
   Google Scholar
• Tabatt K, Kneuer C, Sameti M, Olbrich C, Müller RH, Lehr CM, Bakowsky U. Transfection with different colloidal systems: Comparison of solid lipid nanoparticles and liposomes. J Control Release 2004; 97: 321–32
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Boonme P, Souto EB, Müller RH, Junyaprasert VB. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release 2008; 128: 134–41
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10– Development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm 2007; 67: 141–48
   PubMed Web of Science ®Google Scholar
• Westesen K, Bunjes H, Koch MHJ. Physicochemical characterisation of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 1997; 48: 223–36
   Web of Science ®Google Scholar
• Zhang H, Zhan XN, Cheng B, Tan H. The preparation of solid lipid nanoparticles of bifendate. J Guangdong College Pharma 2007; 23: 37–40
   Google Scholar